Analisis Keuangan Saham BCYC - Bicycle Therapeutics plc - Depositary Receipt (Common Stock) (NasdaqGS) Stock

Gambaran Umum

Bicycle Therapeutics plc, headquartered in Cambridge, UK, operates primarily in the biotechnology industry and focuses on developing transformative medicines through its proprietary bicyclic peptide (Bicycle®) technology. This innovative technology platform enables the creation of new classes of therapeutics which possess the affinity and specificity typical of antibodies, coupled with the tissue penetration ability of small molecules, aimed at treating cancer and other debilitating diseases. Key projects include their lead candidates BT1718, a novel Bicycle Toxin Conjugate targeted at tumors expressing Membrane Type 1 Matrix Metalloproteinase, and BT5528, a second-generation Bicycle Toxin Conjugate aimed at the EphA2 receptor, a target associated with poor prognosis cancers. Their approach to drug development pioneers avenues in oncology, specifically using a tumor-targeted immune cell agonists strategy to activate immune responses against cancers.

Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih

Nilai revenue untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah 19.28 MM.
Nilai operating income untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -288.31 MM.
Nilai net income untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -242.36 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	19.28	-288.31	-242.36
2025-03-31	25.72	-248.36	-203.22
2024-12-31	35.27	-209.87	-169.03
2024-09-30	36.90	-196.44	-166.28
2024-06-30	39.57	-183.40	-165.37
2024-03-31	41.61	-179.86	-168.16
2023-12-31	26.98	-189.95	-180.66
2023-09-30	24.83	-167.92	-161.54
2023-06-30	22.52	-146.88	-139.99
2023-03-31	15.50	-131.07	-124.22
2022-12-31	14.46	-116.65	-112.72
2022-09-30	15.05	-102.47	-100.78
2022-06-30	16.34	-87.00	-87.11
2022-03-31	13.75	-76.98	-78.19
2021-12-31	11.70	-65.62	-66.82
2021-09-30	11.77	-64.65	-66.22
2021-06-30	11.28	-61.04	-61.68
2021-03-31	11.07	-56.34	-55.88
2020-12-31	10.39	-51.96	-51.01
2020-09-30	11.82	-39.66	-37.98
2020-06-30

Laporan Laba Rugi: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31	-3.13	-3.13
2024-12-31	-2.90
2024-09-30	-3.23	-3.23
2024-06-30	-3.74	-3.74
2024-03-31	-4.34	-4.34
2023-12-31	-5.08
2023-09-30	-4.99	-4.99
2023-06-30	-4.68	-4.68
2023-03-31	-4.17	-4.17
2022-12-31	-3.80
2022-09-30	-3.42	-3.42
2022-06-30	-3.07	-3.07
2022-03-31	-2.90	-2.90
2021-12-31	-2.67
2021-09-30	-2.87	-2.87
2021-06-30	-2.85	-2.85
2021-03-31	-2.77	-2.77
2020-12-31	-2.66
2020-09-30	-2.07	-2.07
2020-06-30	-2.07	-2.07

Arus Kas: Operasi, Investasi, Pendanaan

Nilai cash from operating activities untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -208.38 MM.
Nilai cash from investing activities untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -1.91 MM.
Nilai kas dari aktivitas pendanaan untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) per 2025 Jun 30 adalah -31.81 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	-208.38	-1.91	-31.81
2025-03-31	-180.22	-1.83	517.84
2024-12-31	-164.72	-1.24	519.75
2024-09-30	-202.62	-0.92	519.93
2024-06-30	-163.81	-0.98	786.49
2024-03-31	-85.09	-0.84	249.18
2023-12-31	-60.63	-2.93	250.03
2023-09-30	-43.65	-4.33	255.53
2023-06-30	-48.49	-6.81	21.06
2023-03-31	-106.12	-16.33	8.96
2022-12-31	-86.11	-18.99	6.69
2022-09-30	-66.24	-18.61	191.47
2022-06-30	-38.65	-15.79	231.76
2022-03-31	-27.49	-6.16	247.12
2021-12-31	-14.79	-2.03	320.73
2021-09-30	-20.98	-1.45	131.81
2021-06-30	-52.68	-1.37	152.44
2021-03-31	-52.66	-1.50	136.90
2020-12-31	-17.79	-1.20	62.84
2020-09-30	-6.09	-1.11	61.22
2020-06-30

Metrik Penilaian: PE, PriceToBook, PriceToTBV

p/libro untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.65.
p/tbv untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.65.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30		0.65	0.65
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31	-5.67	2.36
2022-12-31		3.02	3.02
2022-09-30		2.22	2.22
2022-06-30	-6.39	1.51	1.51
2022-03-31	-19.53	3.77	3.77
2021-12-31	-27.03	10.48	10.48
2021-09-30	-17.30	7.51	7.51
2021-06-30
2021-03-31	-9.88	3.89	3.89
2020-12-31	-9.71	5.19	5.19
2020-09-30	-12.94	4.49	4.49
2020-06-30	-11.38	5.98	5.98

Metrik Penilaian: EBitToEv, EBit3YrAvgToEv

EBIT/EV untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.67.
EBIT (3 tahun) / EV untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.55.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	0.67	0.55
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31	-0.35	-0.25
2022-12-31	-0.19	-0.13
2022-09-30	-0.25	-0.19
2022-06-30	-0.65	-0.49
2022-03-31	-0.08	-0.06
2021-12-31	-0.04	-0.03
2021-09-30	-0.07	-0.05
2021-06-30
2021-03-31	-0.15	-0.10
2020-12-31	-0.14	-0.09
2020-09-30	-0.11	-0.09
2020-06-30	-0.12	-0.09

Efektivitas Manajemen

roa untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.19.
roe untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.23.
roic untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.27.
croic untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah 0.45.
ocroic untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -0.24.

Period End (TTM)	ROA	ROE	ROIC (Tingkat Pengembalian Investasi Modal)	CROIC	OCROIC
2025-06-30	-0.19	-0.23	-0.27	0.45	-0.24
2025-03-31	-0.31	-0.47	-0.21	0.44	-0.21
2024-12-31	-0.28	-0.45	-0.19	0.37	-0.23
2024-09-30	-0.26	-0.40	-0.18	0.68	-0.18
2024-06-30	-0.39	-0.69	-0.42	0.41	-0.21
2024-03-31	-0.44	-0.67	-0.43	0.45	-0.15
2023-12-31	-0.39	-0.56	-0.35	0.46	-0.09
2023-09-30	-0.31	-0.45	-0.52	-0.12	-0.18
2023-06-30	-0.28	-0.40	-0.52	-0.12	-0.18
2023-03-31	-0.25	-0.34	-0.42	-0.39	-0.36
2022-12-31	-0.36	-0.59	-0.30	0.31	-0.20
2022-09-30	-0.31	-0.51	-0.30	0.31	-0.20
2022-06-30	-0.35	-0.55	-0.24	0.49	-0.11
2022-03-31	-0.30	-0.47	-0.21	0.56	-0.07
2021-12-31	-0.41	-0.69	-0.17	0.78	-0.10
2021-09-30	-0.36	-0.56	-0.32	0.54	-0.30
2021-06-30	-0.52	-0.87	-0.35	0.58	-0.30
2021-03-31	-0.43	-0.68	-0.32	0.49	-0.30
2020-12-31	-0.46	-0.55	-0.46	0.39	-0.16
2020-09-30	-0.33	-0.40	-0.30	0.43	-0.05
2020-06-30	-0.30	-0.36	-0.51	-0.16	-0.10

Gross Margins

marjin kotor untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -6.67.
marjin bersih untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -7.90.
marjin operasi untuk Bicycle Therapeutics plc - Depositary Receipt (Common Stock) pada 2025 Jun 30 adalah -9.66.

Margin Kotor: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Margin Keuntungan Bersih: Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.

Margin Operasi: Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.

Period End (TTM)	Margin Kotor	Margin Keuntungan Bersih	Margin Operasi
2025-06-30	-6.67	-7.90	-9.66
2025-03-31	-3.90	-4.79	-5.95
2024-12-31	-3.38	-4.51	-5.32
2024-09-30	-3.06	-4.18	-4.63
2024-06-30	-2.83	-4.04	-4.32
2024-03-31	-4.80	-6.70	-7.04
2023-12-31	-4.24	-6.51	-6.76
2023-09-30	-4.20	-6.22	-6.52
2023-06-30	-4.41	-6.22	-6.52
2023-03-31	-4.64	-8.01	-8.46
2022-12-31	-3.64	-6.70	-6.81
2022-09-30	-2.52	-6.70	-6.81
2022-06-30	-2.60	-5.33	-5.32
2022-03-31	-2.84	-5.69	-5.60
2021-12-31	-2.57	-5.71	-5.61
2021-09-30	-2.44	-5.62	-5.49
2021-06-30	-2.44	-5.47	-5.41
2021-03-31	-2.17	-5.05	-5.09
2020-12-31	-2.19	-4.91	-5.00
2020-09-30	-1.52	-3.21	-3.35
2020-06-30	-2.31	-4.34	-4.57